Bioactivities of EF24, a Novel Curcumin Analog: A Review
Yonghan He et al, 2018, Front. Oncol. CrossRef
The Curcumin Analogue, EF-24, Triggers p38 MAPK-Mediated Apoptotic Cell Death via Inducing PP2A-Modulated ERK Deactivation in Human Acute Myeloid Leukemia Cells
Pei-Ching Hsiao et al, 2020, Cancers CrossRef
Dienone Compounds: Targets and Pharmacological Responses
Martina Bazzaro et al, 2020, J. Med. Chem. CrossRef
Drug Delivery (Nano)Platforms for Oral and Dental Applications: Tissue Regeneration, Infection Control, and Cancer Management
Pooyan Makvandi et al, 2021, Adv. Sci. CrossRef
Perspectives for synthetic curcumins in chemoprevention and treatment of cancer: an update with promising analogues
Adeoluwa Adeluola et al, 2021, European Journal of Pharmacology CrossRef
Curcumin analog HO‐3867 triggers apoptotic pathways through activating JNK1/2 signalling in human oral squamous cell carcinoma cells
Chi‐Wei Chen et al, 2022, J Cellular Molecular Medi CrossRef
EF-24, a Curcumin Analog, Inhibits Cancer Cell Invasion in Human Nasopharyngeal Carcinoma through Transcriptional Suppression of Matrix Metalloproteinase-9 Gene Expression
Shih-Chi Su et al, 2023, Cancers CrossRef
Therapeutic potential of curcumin and its nanoformulations for treating oral cancer
Diptasree Mukherjee et al, 2023, World J Methodol CrossRef
Nanowired Delivery of Curcumin Attenuates Methamphetamine Neurotoxicity and Elevates Levels of Dopamine and Brain-Derived Neurotrophic Factor
Ilaria Ottonelli et al, 2023 CrossRef
Curcumin and analogues against head and neck cancer: From drug delivery to molecular mechanisms
Chengzhi Zhao et al, 2023, Phytomedicine CrossRef
Anticarcinogenic Potency of EF24: An Overview of Its Pharmacokinetics, Efficacy, Mechanism of Action, and Nanoformulation for Drug Delivery
Iliyana Sazdova et al, 2023, Cancers CrossRef
Nanotechnology and curcumin: a novel and promising approach in digestive cancer therapy
Yi Zhang et al, 2023, Nanomedicine CrossRef